Mochida Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 78%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Feb 7, 2025 2:00 pm JST Earnings

4534 Mochida Pharmaceutical Co.,Ltd. 【J-GAAP】

Earnings Report

Mochida Pharmaceutical Co.,Ltd. <4534> [TSE Prime] announced its financial results in the afternoon session on February 7th (14:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 26.1% from the same period last year, reaching 7.64 billion yen. The progress rate toward the full-year plan of 7.7 billion yen was 99.2%, almost the same as the five-year average of 99.2%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the January to March period (4Q) is expected to turn into a profit of 0.06 billion yen (compared to a loss of 0.02 billion yen in the same period last year).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 77.5% from the same period last year, reaching 3.56 billion yen. The operating profit margin drastically improved from 6.4% in the same period last year to 11.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	81,394	10,356	10,639	8,081	216.5	117.1	Feb 6, 2023	J-GAAP
Apr - Dec, 2023	78,218	5,791	6,059	4,444	123.5	100.4	Feb 5, 2024	J-GAAP
Apr - Dec, 2024	80,731	7,243	7,640	5,605	158.1	99.2	Feb 7, 2025	J-GAAP
YoY	+3.2%	+25.1%	+26.1%	+26.1%	+28.0%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	53,409	1,850	1,984	1,709	47.7	40	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	54,904	3,707	3,621	2,775	78.3	40	Nov 1, 2024	J-GAAP
YoY	+2.8%	+100.4%	+82.5%	+62.4%	+64.2%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	103,261	8,507	9,085	6,649	178.9	80	May 15, 2023	J-GAAP
Mar, 2024	102,885	5,802	6,037	4,547	126.8	80	May 13, 2024	J-GAAP
Mar, 2025 Guidance	106,000	7,500	7,700	5,600	158.0	80	May 13, 2024	J-GAAP
YoY	+3.0%	+29.3%	+27.5%	+23.2%	+24.6%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	28,742	1,839	2,006	1,606	44.6	6.4	Feb 5, 2024	J-GAAP
Jan - Mar, 2024	24,667	11	-22	103	2.9	0.0	May 13, 2024	J-GAAP
Apr - Jun, 2024	25,407	2,189	2,367	1,554	43.9	8.6	Aug 2, 2024	J-GAAP
Jul - Sep, 2024	25,689	1,604	1,712	1,271	35.9	6.2	Nov 1, 2024	J-GAAP
Oct - Dec, 2024	29,635	3,450	3,561	2,780	78.4	11.6	Feb 7, 2025	J-GAAP
YoY	+3.1%	+87.6%	+77.5%	+73.1%	+75.8%